US Broker Ratings

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genetic Sequencing Giant’s Potential Amid Market Volatility

Illumina, Inc. (NASDAQ: ILMN), a key player in the healthcare sector’s diagnostics and research industry, is at the forefront of genetic and genomic analysis worldwide. With a market capitalization of..

Doximity, Inc. (DOCS) Investor Outlook: Analyzing a 39.16% Potential Upside in the Healthcare Sector

Investors with a keen eye on healthcare technology stocks should take note of Doximity, Inc. (NYSE: DOCS), a prominent player in the health information services industry. With a market capitalization..

HealthEquity, Inc. (HQY): Investor Outlook Highlights 18% Upside Potential

For investors seeking to capitalize on growth in the healthcare sector, HealthEquity, Inc. (NASDAQ: HQY) presents an intriguing opportunity. Specializing in technology-enabled services for health savings accounts and related offerings,..

Henry Schein, Inc. (HSIC) Stock Analysis: Insights into a Healthcare Giant with a 7.80% Potential Upside

Investors eyeing the healthcare sector may want to consider Henry Schein, Inc. (NASDAQ: HSIC), a leading player in medical distribution with a robust market capitalization of $8.64 billion. Operating primarily..

Edwards Lifesciences Corporation (EW) Stock Analysis: Navigating Growth with a Potential 8.86% Upside

Edwards Lifesciences Corporation (NYSE: EW), a leading player in the medical devices industry, is a company that has built its reputation on delivering innovative cardiovascular solutions. As investors seek opportunities..

Elanco Animal Health (ELAN) Stock Analysis: Evaluating Growth Potential Amid a 12.94% Upside

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the niche of drug manufacturers focusing on specialty and generic solutions. With a..

Grifols, S.A. (GRFS) Investor Outlook: Analyzing a 43.8% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS) is a notable player in the healthcare sector, specifically within the drug manufacturing industry, with a strong foothold in the plasma therapeutics market. With a market..

Bruker Corporation (BRKR) Stock Analysis: A Look at Its 14.89% Potential Upside

Bruker Corporation (NASDAQ: BRKR), a formidable player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors. With a market capitalization of $6.35 billion,..

argenx SE (ARGX) Stock Analysis: A Biotech Leader with a 4.62% Upside

Investors looking into the biotechnology sector may find argenx SE (ARGX) a compelling opportunity. With a market capitalization of $55.9 billion, this Netherlands-based company has gained significant traction in the..

Insulet Corporation (PODD) Stock Analysis: Target Price Suggests 12% Upside Potential

As the healthcare sector continues to evolve with rapid technological advancements, Insulet Corporation (NASDAQ: PODD) stands out as a key player in the medical devices industry. With a market capitalization..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Exploring a 4.14% Potential Upside in Biotechnology’s Rising Star

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a promising player in the biotechnology sector, is gaining traction among investors for its innovative approach to tackling metabolic dysfunction-associated steatohepatitis (MASH). With its flagship..

BridgeBio Pharma (BBIO) Investor Outlook: Riding a Wave of 4,318% Revenue Growth and Intriguing Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO) has captured investor attention within the biotechnology space, primarily due to its remarkable revenue growth and compelling potential for upside. The company, which operates out..

Gilead Sciences, Inc. (GILD) Rating Update: Strong Buy Ratings with a 4.47% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a heavyweight in the healthcare sector, continues to capture investor interest with its formidable presence in the biopharmaceutical landscape. With a market capitalization of $155.33..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Strong Buy Ratings Highlight a Promising 14.70% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV) has captured the attention of investors and analysts alike, operating at the cutting edge of the biotechnology sector. With its roots in the United Kingdom..

Cardinal Health, Inc. (CAH) Stock Analysis: Navigating Growth with a 3.44% Upside Potential

Cardinal Health, Inc. (NYSE: CAH), a stalwart in the healthcare sector, presents a compelling opportunity for investors as it continues to demonstrate robust growth and strategic positioning within the medical..

Corcept Therapeutics (CORT) Stock Analysis: A Promising 79% Upside in the Biotech Sector

For investors seeking opportunities within the biotechnology sector, Corcept Therapeutics Incorporated (NASDAQ: CORT) presents a compelling case. With a market capitalization of $7.97 billion, this Redwood City, California-based company has..

The Ensign Group, Inc. (ENSG) Stock Analysis: Unlocking a 13% Upside in the Healthcare Sector

Investors seeking a robust opportunity in the healthcare sector might find The Ensign Group, Inc. (NASDAQ: ENSG) an enticing prospect. With a market capitalization of $10.3 billion, Ensign Group operates..

Avantor, Inc. (AVTR) Stock Analysis: Navigating the Healthcare Sector with a 19.88% Potential Upside

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, is capturing investor attention with its substantial potential upside of 19.88%. As a company dedicated to providing mission-critical products..

Repligen Corporation (RGEN) Investor Outlook: A Healthcare Pioneer with 22.73% Upside Potential

Repligen Corporation (NASDAQ: RGEN) stands out in the healthcare sector with its innovative approach to bioprocessing technologies, catering to life sciences and biopharmaceutical giants globally. With a market capitalization of..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Strong Buy with 33.89% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is capturing the attention of investors with its robust portfolio of innovative treatments and promising growth prospects. Headquartered in Dublin, Ireland, Jazz operates within the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds